| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Nasdaq's $62M payout for Facebook IPO approved

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

FB $25.14 -$0.59

at close on MONDAY

Daily Photo Galleries

By Stuart Pfeifer
Tuesday, March 26, 2013, 12:01 a.m.

The Securities and Exchange Commission has approved Nasdaq OMX Group Inc.'s proposal to pay brokerages as much as $62 million as compensation for last year's botched Facebook Inc. initial public offering.

Nasdaq's trading system was overwhelmed by high volume on the first day that Facebook's stock traded, delaying trade confirmations and contributing to a chaotic and costly day for investors in the social media company.

By some accounts, Wall Street firms lost as much as $500 million because of Nasdaq glitches during the Facebook IPO in May.

Brokerages complained that they didn't get confirmation that trades were going through, leaving investors in the dark about whether they owned the stock, or at what price. The problem was magnified as shares of the stock plunged after opening higher than expected.


Subscribe today! Click here for our subscription offers.

Show commenting policy

Most-Read Stories

  1. Thousands in Spain protest ban on demonstrations, burning national flag
  2. Washington County gas pipeline fire prompts evacuations
  3. Pitt set to hire Michigan State’s Narduzzi as coach
  4. Starkey: Steelers have only one goal
  5. Ex-Penguin Orpik: It was time for change
  6. Ex-Steeler Russell tackles big problem for little ones
  7. Former Army Ranger learns Steelers Way
  8. Pittsburgh police chief places officer who shot Leon Ford on desk duty
  9. Christmas customs fade as family dynamics evolve
  10. Steelers notebook: LeBeau says Timmons deserving of accolades
  11. Former Mt. Pleasant Area employee accused of stealing prescription drugs